Wells Fargo analyst Larry Biegelsen raised the firm’s price target on Penumbra to $337 from $320 and keeps an Overweight rating on the shares. The firm notes that Penumbra’s Q2 sales beat was driven by Neuro, and raised 2023 sales guidance largely reflects the beat.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on PEN:
- Penumbra price target lowered to $345 from $370 at Truist
- Penumbra price target lowered to $322 from $351 at Canaccord
- Penumbra price target lowered to $308 from $351 at BTIG
- Penumbra raises FY23 revenue view to $1.05B-$1.07B from $1.04B-$1.06
- Penumbra reports Q2 EPS 48c, consensus 28c
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue